Keyphrases
Omalizumab
100%
MiRNA Signature
100%
Moderate-to-severe Asthma
100%
Ensemble Feature Selection
100%
Asthma Patients
50%
Regulatory Subunit
33%
Protein Phosphatase
33%
Coiled-coil Domain
33%
Explainable Network
33%
Clinical Significance
16%
MRNA Expression
16%
Treatment Options
16%
Clinical Setting
16%
Inhaled Corticosteroids
16%
Mucosal Immunity
16%
Current Treatment
16%
Computational Approach
16%
Cohort Data
16%
Add-on Therapy
16%
5 Gene
16%
Literature Research
16%
Airway Remodeling
16%
Computational Methods
16%
Feature Rules
16%
Severe Asthma
16%
Bronchodilator
16%
Computational Algorithm
16%
Expression Data
16%
Solute Carrier Family
16%
Number of Features
16%
Long-acting β2-agonist
16%
Network Algorithms
16%
Cell Metabolism
16%
Metabolic Remodeling
16%
Machine Learning Based
16%
Rule-based Algorithm
16%
SLC26A8
16%
SLC26A
16%
Anti-IgE Therapy
16%
C-type Lectin Domain
16%
Immunity Cells
16%
Biochemistry, Genetics and Molecular Biology
Omalizumab
100%
Messenger RNA
100%
Feature Extraction
100%
Coiled Coil
33%
Protein Phosphatase 1
33%
C-Type Lectin
16%
CLEC4C
16%
Agonist
16%
Cell Metabolism
16%
Solute Carrier Family
16%
Mucosal Immunity
16%
Immunoglobulin E
16%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Omalizumab
100%
Messenger RNA
100%
Phosphoprotein Phosphatase 1
33%
Add on Therapy
16%
Biological Marker
16%
Lectin
16%
Bronchodilating Agent
16%
Solute Carrier Protein
16%
Airway Remodeling
16%
Immunoglobulin E
16%